东阿阿胶(000423) - 2024 Q2 - 季度财报

Financial Performance - The company's revenue for the first half of 2024 reached ¥2,747,957,878.26, representing a 26.80% increase compared to ¥2,167,139,023.14 in the same period last year[16]. - Net profit attributable to shareholders was ¥738,419,138.16, a 39.03% increase from ¥531,113,560.00 year-on-year[16]. - The net profit after deducting non-recurring gains and losses was ¥699,577,867.77, up 42.79% from ¥489,944,263.46 in the previous year[16]. - Basic earnings per share increased to ¥1.1489, a rise of 39.31% from ¥0.8247[16]. - The company's operating revenue for the reporting period was ¥2,747,957,878.26, representing a year-on-year increase of 26.80% compared to ¥2,167,139,023.14 in the same period last year[26]. - Operating profit increased to ¥878,663,980.28, up 35.5% from ¥647,895,376.14 year-over-year[95]. - The total profit for the first half of 2024 was ¥882,770,666.07, a 36.2% increase from ¥648,012,058.43 in the same period of 2023[95]. - The company's total comprehensive income for the first half of 2024 was ¥738,411,722.68, compared to ¥531,878,154.94 in the previous year, reflecting a 38.8% increase[95]. Cash Flow and Assets - The net cash flow from operating activities was ¥922,069,401.63, reflecting a 22.57% increase compared to ¥752,303,456.45 in the same period last year[16]. - The company's cash and cash equivalents decreased by ¥605,182,521.38, a decline of 330.29% compared to an increase of ¥262,788,286.96 in the previous year[26]. - The company's total assets at the end of the reporting period were ¥12,500,395,127.16, down 6.06% from ¥13,306,306,533.41 at the end of the previous year[16]. - The company's cash and cash equivalents at the end of the period amounted to ¥5,220,324,810.90, down from ¥5,825,507,332.28 at the beginning of the period, representing a decrease of approximately 10.4%[184]. - The total accounts receivable at the end of the period amounted to ¥706,669,656.52, an increase from ¥425,335,652.62 at the beginning of the period, representing a growth of 66.1%[192]. Dividend and Shareholder Information - The board approved a cash dividend of ¥11.44 per 10 shares, based on a total of 643,976,824 shares[7]. - A cash dividend of CNY 11.44 per 10 shares (including tax) will be distributed, totaling CNY 736,709,486.66, which represents 110.53% of the parent company's net profit for the first half of 2024[45]. - The total number of common shareholders at the end of the reporting period was 44,108, with the top 10 shareholders holding 32.50% of the total share capital[78]. - China Resources Dong'e Ejiao Co., Ltd. holds 23.50% of the total share capital, amounting to 151,351,731 shares[78]. Research and Development - The company has developed proprietary technology for its products, enhancing convenience with instant consumption options[5]. - The company has established a unique research and innovation platform, including the "National Engineering Research Center for Gelatin Chinese Medicine," to address key industry challenges[24]. - Dong'e Ejiao has developed over 40 strategic reserve products, expanding its product portfolio to meet diverse consumer needs[23]. - The company has partnered with various research institutions to explore the applications of Ejiao in chronic musculoskeletal diseases, furthering its R&D capabilities[25]. Environmental and Social Responsibility - The company invested CNY 1.8395 million in environmental governance and protection in the first half of 2024, and paid CNY 1.4144 million in water resource tax in the same period[51]. - The company generated 2.1221 million kWh of photovoltaic power from rooftop solar panels, accounting for 16.85% of the total electricity consumption in the industrial park, reducing carbon dioxide emissions by 2,115 tons[51]. - The company completed the re-certification of its pollutant discharge permit in June 2022, valid until June 2027, ensuring compliance[49]. Risks and Challenges - The company is facing long-term risks due to the decline in the number of donkeys raised and the need for time-consuming research in breeding and disease prevention[40]. - The company plans to optimize its raw material supply mechanism and drive both domestic and international markets to ensure sustainable raw material safety[41]. Financial Management and Investments - The company has engaged in entrusted wealth management with a total amount of RMB 3.2 billion, with an outstanding balance of RMB 2.8 billion[65]. - The company has no overdue amounts or impairment provisions for entrusted wealth management products[65]. - The company has confirmed that all entrusted wealth management plans have followed legal procedures and will continue to have such plans in the future[67][68]. Inventory and Receivables Management - Inventory decreased from CNY 1,012,458,003.98 to CNY 960,807,163.63, a decline of about 5.11%[87]. - The provision for bad debts at the end of the period was ¥373,179,754.94, which is 52.81% of the total accounts receivable[197]. - The aging analysis shows that accounts receivable within one year amounted to ¥345,757,866.18, significantly higher than the previous period's ¥64,490,795.61[192]. Corporate Governance - The company has not implemented any stock incentive plans or employee stock ownership plans during the reporting period[47]. - The company has not reported any expected inability to recover principal or other impairment risks related to entrusted financial management[70].